Pivotal role of CCR1-positive leukocytes in bleomycin-induced lung fibrosis in mice

被引:86
作者
Tokuda, A
Itakura, M
Onai, N
Kimura, H
Kuriyama, T
Matsushima, K
机构
[1] Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan
[2] Chiba Univ, Sch Med, Dept Chest Med, Chiba 280, Japan
关键词
D O I
10.4049/jimmunol.164.5.2745
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have investigated the involvement of chemokine receptor CCR1-positive cells in bleomycin-induced lung injury, a model of pulmonary fibrosis. After bleomycin challenge in C57BL/6J mice, the expression of CCR1 mRNA increased and peaked at day 7, which paralleled to the expression of its ligands, macrophage-inflammatory protein-1 alpha and RANTES, Immunohistochemical study showed that CCR1-positive cells accumulated in the interstitial inflammatory site. Furthermore, the treatment of anti-CCR1 Ab significantly reduced the accumulation of inflammatory cells and collagen deposition, resulting in dramatic improvement of survival. These results suggest that CCR1-positive cells play significant roles in the pathogenesis of pulmonary fibrosis subsequent to bleomycin-induced lung injury, and that CCR1 could be a novel molecular target for intervention therapy against pulmonary fibrosis.
引用
收藏
页码:2745 / 2751
页数:7
相关论文
共 31 条
  • [1] Chemokines and leukocyte traffic
    Baggiolini, M
    [J]. NATURE, 1998, 392 (6676) : 565 - 568
  • [2] Blocking chemokine receptors
    Baggiolini, M
    Moser, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) : 1189 - 1191
  • [3] Eosinophil chemotactic activity in bronchoalveolar lavage from idiopathic pulmonary fibrosis is dependent on cytokine priming of eosinophils
    Boomars, KA
    Schweizer, RC
    Zanen, P
    van den Bosch, JMM
    Lammers, JWJ
    Koenderman, L
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (05) : 1009 - 1014
  • [4] Impaired host defense, hematopoiesis, guanulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1
    Gao, JL
    Wynn, TA
    Chang, Y
    Lee, EJ
    Broxmeyer, HE
    Cooper, S
    Tiffany, HL
    Westphal, H
    KwonChung, J
    Murphy, PM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (11) : 1959 - 1968
  • [5] Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury
    Gerard, C
    Frossard, JL
    Bhatia, M
    Saluja, A
    Gerard, NP
    Lu, B
    Steer, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) : 2022 - 2027
  • [6] EFFECT OF ANTIBODY TO TRANSFORMING GROWTH-FACTOR-BETA ON BLEOMYCIN-INDUCED ACCUMULATION OF LUNG COLLAGEN IN MICE
    GIRI, SN
    HYDE, DM
    HOLLINGER, MA
    [J]. THORAX, 1993, 48 (10) : 959 - 966
  • [7] Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor
    Hesselgesser, J
    Ng, HP
    Liang, M
    Zheng, W
    May, K
    Bauman, JG
    Monahan, S
    Islam, I
    Wei, GP
    Ghannam, A
    Taub, DD
    Rosser, M
    Snider, RM
    Morrissey, MM
    Perez, HD
    Horuk, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) : 15687 - 15692
  • [8] Keane MP, 1999, J IMMUNOL, V162, P5511
  • [9] Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases
    Kodama, N
    Yamaguchi, E
    Hizawa, N
    Furuya, K
    Kojima, J
    Oguri, M
    Takahashi, T
    Kawakami, Y
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 18 (04) : 526 - 531
  • [10] Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor
    Kurihara, T
    Warr, G
    Loy, J
    Bravo, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) : 1757 - 1762